COMBINATION OF A TLR3 LIGAND AND A CHEMOTHERAPY AGENT WHICH ACTS ON THE INTRINSIC 'APOPTOSIS' PATHWAY IN THE TREATMENT OF CANCER

摘要

The present invention relates to a medicament comprising, separately or together, (i) a TLR3 ligand and (ii) a chemotherapy agent which acts on the intrinsic apoptosis pathway, for simultaneous or sequential administration in the treatment of cancer, the chemotherapy agent being selected from topoisomerase 2 inhibitors, platinum-derived alkylating agents and PI3 kinase inhibitors.